Merck, CBL198, Anti-Cytokeratin 19 Antibody, clone BA 17

Immunogen
Human reduction mammoplasty organoids
Application
Detect Cytokeratin 19 using this Anti-Cytokeratin 19 Antibody, clone BA 17 validated for use in WB, IC, IH(P).
Immunocytochemistry

Western blotting

Suitable for staining frozen and paraffin wax embedded tissue sections after proteolytic enzyme digestion

Cytokeratin 19 positive detection distinguishes malignant from benign breast tumours

Optimal working dilutions must be determined by the end user.
Research Category
Cell Structure
Research Sub Category
Cytokeratins
Biochem/physiol Actions
The antibody is specific to human cytokeratin 19 and is reactive with cells of epithelial origin. Cytokeratin 19 is the smallest human cytokeratin (40 kDa) and is found in many simple and invariably in some non-keratinising stratified squamous epithelia. All adenocarcinomas tested have been positive for cytokeratin 19.

FUSION PARTNER: Px63 Ag 8.653 myeloma cell line
Physical form
Format: Purified
The monoclonal is presented at a concentration of 0.1mg/1ml in phosphate buffered saline containing 10mM sodium azide and 1% bovine serum albumin. We recommend that each laboratory determine an optimum working titre for use in its particular application.
Preparation Note
For use within 1 month of purchase store at +4°C, for long term storage aliquot antibody into small volumes and store at -20°C.
Other Notes
Replaces: CBL178
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.